🇺🇸 Latanoprost/Timolol in United States

275 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 31 reports (11.27%)
  2. Dizziness — 30 reports (10.91%)
  3. Fall — 30 reports (10.91%)
  4. Off Label Use — 29 reports (10.55%)
  5. General Physical Health Deterioration — 28 reports (10.18%)
  6. Nausea — 27 reports (9.82%)
  7. Dyspnoea — 26 reports (9.45%)
  8. Anaemia — 25 reports (9.09%)
  9. Febrile Neutropenia — 25 reports (9.09%)
  10. Fatigue — 24 reports (8.73%)

Source database →

Other Ophthalmology approved in United States

Frequently asked questions

Is Latanoprost/Timolol approved in United States?

Latanoprost/Timolol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Latanoprost/Timolol in United States?

Universiti Kebangsaan Malaysia Medical Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.